bluebird bio
Rachel Chevalier possesses extensive experience in quality control and analytical development within the biotechnology sector. Currently serving as Director of Quality Control at bluebird bio since November 2019, Rachel has held various pivotal roles at the same company since October 2015, including Associate Director and Senior Manager, demonstrating a progressive career path. Prior to this, Rachel worked as a Scientist in QC Analytics at Dragonfly Therapeutics, Inc., and held roles at Shire Pharmaceuticals and Imugen, Inc. Rachel earned a Bachelor of Science in Biochemistry from Northeastern University in 2013.
bluebird bio
40 followers
bluebird bio is developing innovative gene therapies for severe genetic diseases and cancer. Its vision is to make the hope of gene therapy a reality.